Skip to main content
TARA logo

Protara Therapeutics, Inc.

TARANASDAQHealthcareBiotechnology

$2.44Today:- (-)1Y −52.71%

As of Oct 22, 2026 close

Market cap
$148.86M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.30$7.82
Volume (live)
-
Avg. volume (3M)
1.55M

Protara Therapeutics (TARA) Financial Ratios

For fiscal 2025 (fiscal year ended Dec 31, 2025), Protara Therapeutics had return on equity of -31.6% (up from -37.9%), debt-to-equity of 0.02 (down from 0.03), a current ratio of 14.58 (down from 15.71) and return on assets of -20.6% (up from -23.6%). A current ratio of 14.58 means current assets exceed current liabilities.

Protara Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/B Ratio1.451.520.310.300.471.36
Price/Tangible Book1.451.520.310.300.571.60
Enterprise Value Ratios
Profitability & Returns
Return on Equity (ROE)-31.60%-37.88%-47.44%-49.96%-26.17%-34.47%
Return on Assets (ROA)-20.64%-23.59%-28.36%-16.42%-15.80%-21.07%
Return on Capital Employed (ROCE)-32.50%-28.80%-59.90%-34.90%-28.20%-17.20%
Leverage & Solvency Ratios
Debt/Equity0.020.030.080.060.040.01
Liquidity Ratios
Current Ratio14.5815.7111.1715.0121.6658.13
Quick Ratio14.3415.5410.7114.7821.3757.84
Efficiency Ratios
Yield & Distribution Ratios
Earnings Yield-20.11%-17.59%-189.67%-218.41%-62.30%-12.52%
FCF Yield-19.77%-14.15%-176.45%-88.01%-46.28%-8.95%
Buyback Yield-108.01%-81.73%-0.64%-0.24%-55.28%-180.66%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Protara Therapeutics Financial Ratios

What is Protara Therapeutics's return on equity?

Protara Therapeutics's return on equity (ROE) was -31.6% for fiscal 2025 (period ended Dec 31, 2025). It was -37.9% a year earlier.

What is Protara Therapeutics's debt-to-equity ratio?

Protara Therapeutics's debt-to-equity ratio was 0.02 for fiscal 2025 (period ended Dec 31, 2025). It was 0.03 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition